Skip to content

Intubated ICU Patients

Impact of the Endotracheal Tube on Airway Inflammation: Prospective Analysis in Intubated ICU Patients

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02171091
Enrollment
8
Registered
2014-06-23
Start date
2016-12-01
Completion date
2017-08-08
Last updated
2018-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Requiring Endotracheal Intubation

Keywords

endotracheal, intubation, airway, inflammation

Brief summary

The purpose of this research study is to determine how cell changes during endotracheal intubation and artificial lung ventilation affect lung inflammation. Patients will undergo placement of an endotracheal tube (ETT) as standard of care. Tracheal (windpipe) lavage will be obtained each day for up to 72 hours. Lung samples or fiberoptic (lung) samples will be collected at the same time intervals when possible and if they are done as standard of care. Blood samples will be obtained simultaneous with the collection of the trachael (windpipe) specimens.

Interventions

None listed

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Ages 18 to 85 2. Required to have endotracheal intubation 3. Admitted to an intensive care unit

Exclusion criteria

1. On immunosuppressive medications 2. Previous tracheal surgery 3. On azithromycin 4. Pregnancy 5. Cancer

Design outcomes

Primary

MeasureTime frameDescription
Neutrophil changes72 hoursIdentifying indicators of neutrophil inflammatory changes that occur during 72 hours of tracheal injury secondary to endotracheal intubation.

Secondary

MeasureTime frameDescription
analyze neutrophil activation72 hoursAnalyze neutrophil activation in the distal airways in biological samples obtained simultaneously with tracheal samples and to correlate them with the development of lung inflammation.
correlate tracheal and lung neutrophil activation72 hoursCorrelate tracheal and lung neutrophil activation with development of pneumonia in ICU patients requiring mechanical ventilation.
determine the impact of airway (tracheal, lung) inflammation72 hoursDetermine the impact of airway (tracheal, lung) inflammation as determined by neutrophil activation on the length of stay (LOS), discharge, and readmission to ICU in the first 90 days post airway inflammation (VAP) diagnosis.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026